Canadians will finally be able to get a second dose of the COVID-19 vaccine with a product other than the one they received in the first dose, the National Advisory Committee on Immunization (NACI) has ruled.
• Read also: Quebec celebrates its return to the orange zone
• Read also: Developments on the May 31 coronavirus
The news, rumored in the morning by media in English Canada, is to be officially announced Tuesday at noon at a press conference.
Under the announcement, Canadians should be able to receive a vaccine of the same type they received in their first dose, with no preference for the product. Thus, people who have received a messenger RNA vaccine such as those from Moderna or Pfizer / BioNTech will be able to receive either of these sera as a second dose, without preference.
It should be remembered, however, that the CCNI only has an advisory role and that it will be up to the provinces to decide thereafter.
At the end of May, the Committee had nevertheless taken a position against the mixing of vaccines, but had partially opened the door to this idea which would facilitate the vaccination campaign from a logistical point of view.
Manitoba did not wait for NACI’s advice. On Monday, the Prairie province – currently the most affected by the virus in the country – announced that it would allow the use of Pfizer and Moderna vaccines for the second doses of people vaccinated in the first place with the AstraZenaca vaccine or its Indian version Covishield.